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Multiple pathways link expression of PTR2, the transporter of
di- and tripeptides in the yeast Saccharomyces cerevisiae, to the
availability and quality of nitrogen sources. Previous work has
shown that induction of PTR2 by extracellular amino acids
requires, in particular, SSY1 and PTR3. SSY1 is structurally sim-
ilar to amino acid transporters but functions as a sensor of
amino acids. PTR3 acts downstream of SSY1. Expression of the
PTR2 peptide transporter is induced not only by amino acids
but also by dipeptides with destabilizing N-terminal residues.
These dipeptides bind to UBR1, the ubiquitin ligase of the
N-end rule pathway, and allosterically accelerate the UBR1-de-
pendent degradation of CUP9, a transcriptional repressor of
PTR2. UBR1 targets CUP9 through its internal degron. Here we
demonstrate that the repression of PTR2 by CUP9 requires
TUP1 and SSN6, the corepressor proteins that form a complex
with CUP9. We also show that the induction of PTR2 by amino
acids is mediated by the UBR1-dependent acceleration of CUP9
degradation that requires both SSY1 and PTR3. The accelera-
tion of CUP9 degradation is shown to be attained without
increasing the activity of the N-end rule pathway toward sub-
strates with destabilizing N-terminal residues. We also found
that GAP1, a general amino acid transporter, strongly contrib-
utes to the induction of PTR2 by Trp. Although several aspects
of this complex circuit remain to be understood, our findings
establish new functional links between the amino acids-sensing
SPS system, the CUP9-TUP1-SSN6 repressor complex, the
PTR2peptide transporter, and theUBR1-dependentN-end rule
pathway.
Biological processes addressed by this study include the
mechanisms and regulation of peptide import. Peptides can
serve as a source of amino acids and nitrogen in all organisms.
The import of di- and tripeptides (di/tripeptides) in the yeast
Saccharomyces cerevisiae has been shown to be regulated by the
N-end rule pathway, one proteolytic pathway of the ubiquitin
(Ub)4-proteasome system (1–4). The N-end rule relates the in
vivohalf-life of a protein to the identity of itsN-terminal residue
(reviewed in Refs. 5–7). Although prokaryotes lack the Ub sys-
tem, they still contain the N-end rule pathway, albeit Ub-inde-
pendent versions of it (6, 8, 9). In eukaryotes, this pathway rec-
ognizes several kinds of degradation signals (degrons),
including a set called N-degrons (5–7, 10). Specific N-degrons
that are active (recognized) in a cell give rise to that cell’s N-end
rule. The determinants of an N-degron in a substrate protein
are a destabilizing N-terminal residue that bears the unmodi-
fied N-terminal amino group, a substrate’s internal Lys residue
(the site of formation of a poly-Ub chain), and a nearby confor-
mationally disordered region (11–13).
The N-end rule has a hierarchic structure. In eukaryotes,
N-terminal Asn and Gln are tertiary destabilizing residues in
that they function through their enzymatic deamidation, to
yield the secondary destabilizing N-terminal residues Asp and
Glu (Ref. 7, and references therein). Destabilizing activity of
N-terminal Asp and Glu requires their conjugation to Arg, one
of the primary destabilizing residues, by the ATE1-encoded
Arg-tRNA-protein transferase (arginyl-transferase or R-trans-
ferase) (14–18). In mammals and other eukaryotes that pro-
duce nitric oxide (NO), the set of arginylated residues contains
not only Asp and Glu but also N-terminal Cys, which is arginy-
lated after its oxidation to Cys-sulfinate or Cys-sulfonate (14).
The in vivo oxidation of N-terminal Cys requires NO, as well as
oxygen (O2) or its derivatives (15, 18). The N-end rule pathway
is thus a sensor of NO, through the ability of this pathway to
destroy proteins with N-terminal Cys, at rates controlled by
NO, O2, and their derivatives.
E3 Ub ligases of the N-end rule pathway are called
N-recognins (7, 10, 19). They recognize (bind to) primary desta-
bilizing N-terminal residues. (The term “Ub ligase” denotes
either an E2–E3holoenzymeor its E3 component.) At least four
N-recognins, including UBR1, mediate the N-end rule pathway
inmammals and othermulticellular eukaryotes (7). The known
N-recognins share a 70-residue motif called the UBR box.
Mouse UBR1 and UBR2 are sequelogous (similar in sequence)
200-kDa RING-type E3 Ub ligases that are 47% identical. Sev-
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eral other mammalian N-recognins, either confirmed or puta-
tive ones, are HECT-type or SCF-type Ub ligases that share the
UBRmotif with the RING-type UBR1 andUBR2 but are largely
nonsequelogous to them otherwise (20, 21).5
The functions of theN-end rule pathway include: (i) the sens-
ing of heme, owing to inhibition, in both yeast andmammals, of
the ATE1 R-transferase by hemin (Fe3-heme), which also
inhibits N-recognins, the latter at least in yeast; (ii) the sensing
of NO and O2, and the resulting control of signaling by trans-
membrane receptors, through the conditional, NO/O2-medi-
ated degradation of G-protein regulators RGS4, RGS5, and
RGS16; (iii) regulation of import of short peptides, through the
degradation, modulated by peptides, of CUP9, the repressor of
import; (iv) fidelity of chromosome segregation, through deg-
radation of a separase-produced cohesin fragment; (v) regula-
tion of apoptosis, through degradation of a caspase-processed
inhibitor of apoptosis; (vi) amultitude of processesmediated by
the transcription factor c-FOS, a conditional substrate of the
N-end rule pathway; (vii) regulation of the human immunode-
ficiency virus replication cycle, through degradation of human
immunodeficiency virus integrase; and (viii) regulation of mei-
osis, spermatogenesis, neurogenesis, and cardiovascular devel-
opment in mammals, and leaf senescence in plants (Refs. 2–4,
7, 14, 15, 17–19, 23–25, and references therein). Mutations in
humanUBR1, one of the E3s of the N-end rule pathway, are the
cause of Johansson-Blizzard syndrome, which comprises men-
tal retardation, physical malformations, and severe pancreatitis
(26).
The N-end rule pathway of S. cerevisiae is mediated by a
single N-recognin, UBR1, a 225-kDa sequelog of mammalian
UBR1 and UBR2 (2, 10, 27). S. cerevisiaeUBR1 contains at least
three substrate-binding sites. The type-1 site is specific for basic
N-terminal residues of polypeptides (Arg, Lys, and His). The
type-2 site is specific for bulky hydrophobic N-terminal resi-
dues (Trp, Phe, Tyr, Leu, and Ile). The third binding site of
UBR1 recognizes an internal (non-N-terminal) degron in target
proteins. The third binding site of UBR1 is autoinhibited but
can be allosterically activated through a conformational change
that is caused by the binding of short peptides, such as dipep-
tides, to the other, type-1 and type-2, binding sites of UBR1.
The known substrate of the third binding site of UBR1 is CUP9
(1–3), a homeodomain protein and transcriptional regulator,
largely a repressor, of more than 30 genes in S. cerevisiae.6 The
regulon of CUP9 includes PTR2, a gene encoding the main
transporter of di/tripeptides (28, 29). The reversal of UBR1
autoinhibition by imported di/tripeptides with destabilizing
N-terminal residues accelerates the UBR1-dependent ubiqui-
tylation of CUP9, leads to its faster degradation, and thereby
causes a derepression of PTR2. The resulting positive-feedback
circuit allows S. cerevisiae to detect the presence of extracellular
peptides and to react by increasing their uptake (2, 3).
The evolution of peptide-import circuits is under conflicting
selective pressures, because the ability of a cell to import pep-
tides confers both a benefit (utilization of peptides as food) and
a vulnerability to toxins that resemble short peptides. Although
PTR2 is the major transporter of di/tripeptides in S. cerevisiae,
some di/tripeptides can also be imported (with a low efficacy)
by DAL5, whose major function is the import of other nitrogen
sources, such as allantoate and ureidosuccinate (4). Another set
of S. cerevisiae peptide transporters comprises OPT1 (HGT1)
and OPT2, which have partially overlapping functions, do not
import di/tripeptides, but can import peptides of 4–5 residues.
In addition, OPT1 (HGT1) is a high affinity importer of gluta-
thione, a “noncanonical” tripeptide (Ref 30, and references
therein). Similarly to the PTR2 transporter of di/tripeptides, the
expression of OTP2 is down-regulated by CUP9, whereas the
expression of OPT1 (HGT1) is independent of CUP9 (30). In
addition to PTR2 and OPT2, the N-end rule pathway also con-
trols the expression of DAL5, but in a manner opposite to that
of the other two transporters: whereas CUP9 is a transcrip-
tional repressor of PTR2 and OPT2, CUP9 apparently up-reg-
ulates the expression of DAL5 (28, 30). It is unknown whether
CUP9 down-regulates a repressor of DAL5 or whether CUP9
acts, in the context of DAL5, as a transcriptional activator.
The induction of the PTR2 peptide transporter by di/tripep-
tides, a process controlled by the UBR1-CUP9 circuit (3), is just
one of regulatory inputs that couple PTR2 expression to the
availability and quality of nutrients. For example, PTR2 expres-
sion is down-regulated by certain nitrogen sources, including
ammonia, but not by other nitrogen sources, such as urea and
allantoin (31). The underlying systems, including the N-end
rule pathway, ensure that a cell does not waste resources syn-
thesizing large amounts of the PTR2 transporter in the absence
of extracellular peptides, or when a more efficacious nitrogen
source, such as ammonia, is present.
PTR2 is also induced by extracellular amino acids, particu-
larly leucine or tryptophan (32). This response is likely to be
adaptive in natural habitats, because the amino acids that S.
cerevisiae (a scavenging heterotroph) encounters outside the
laboratory tend to be the breakdown products of peptides and
thus signify a likely presence of di/tripeptides. In addition, it has
not been precluded that the S. cerevisiae PTR2 transporter
might itself import amino acids, in addition to peptides. For
example, AtPTR2 andAtCHL1,members of the PTR2 family in
the plant Arabidopsis thaliana, transport histidine and nitrate,
respectively (Ref. 33, and references therein). Either of the
above possibilities may underlie the fact that amino acids reg-
ulate PTR2 expression.
Extracellular amino acids regulate PTR2 through the SPS
(SSY1-PTR3-SSY5) pathway (34–40). SSY1, an integral mem-
brane protein and a sensor of amino acids, is a sequelog of
amino acid transporters but does not function as a transporter
(36, 37, 41), a disposition that recurswith other nutrient sensors
as well (37, 42). Both the inferred design of SSY1 and experi-
mental evidence suggest that it is the concentration ratio of an
amino acid across the plasmamembrane, rather than the abso-
5 A note on terminology: “sequelog” and “spalog” denote, respectively, a
sequence that is similar, to a specified extent, to another sequence, and a
three-dimensional structure that is similar, to a specified extent, to another
three-dimensional structure (22). Besides their usefulness as separate
terms for sequence and spatial similarities, the rigor-conferring advantage
of sequelog and spalog is their evolutionary neutrality, in contrast to inter-
pretation-laden terms such as “homolog,” “ortholog,” and “paralog.” The
latter termsare compatiblewith the sequelog/spalog terminologyandcan
beused to conveyunderstandingabout functions andcommondescent, if
this (additional) information is available.
6 C. S. Hwang and A. Varshavsky, unpublished data.
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lute concentration of extracellular amino acid that determines
the signaling output by SSY1 (36). Activated SSY1 induces
expression of a regulon that includes the PTR2 peptide trans-
porter and amino acid transporters such asAGP1, BAP2, BAP3,
TAT1, TAT2, and GNP1 (38). PTR3 and SSY5 are peripheral
membrane proteins associated with SSY1 (41). SSY5 is a prote-
ase regulated, in particular, by PTR3. SSY5 can cleave, and
thereby activate, the latent (conditionally cytosolic) transcrip-
tional activators STP1 and STP2, leading to their import into
the nucleus and the induction of genes that encode, in particu-
lar, amino acid transporters (34–37, 39, 40, 43).
In the presentwork, we show that an extracellular amino acid
such as Trp acts via the SPS system to induce the PTR2-medi-
ated import of di/tripeptides through the acceleration of deg-
radation of CUP9 (the repressor of import) by the UBR1-de-
pendent N-end rule pathway. The bulk of this effect of Trp on
the rate of CUP9 degradation requires both SSY1 and PTR3. At
the same time, no significant activation of the N-end rule path-
way toward substrates with destabilizing N-terminal residues
(i.e. toward substrates with N-degrons) was observed under
these conditions, suggesting a differential regulation of three
substrate-binding sites of the UBR1 Ub ligase. We also show
that the repression of PTR2 by CUP9 requires the global core-
pressors TUP1 and SSN6, and that GAP1, a general amino acid
transporter, strongly contributes to the induction of PTR2 by
Trp. Although several aspects of this complex circuit remain to
be understood, our findings establish new functional links
between the amino acids-sensing SPS system, theCUP9-TUP1-
SSN6 repressor complex, the PTR2 peptide transporter, and
the UBR1-dependent N-end rule pathway.
EXPERIMENTAL PROCEDURES
Yeast Strains, Plasmids, andGenetic Techniques—The S. cer-
evisiae strains used in this study are described in Table 1.
AVY24 and AVY25 were constructed in the background of
strain RJD347 (MAT ura3–52; a gift from Dr. R. Deshaies,
California Institute of Technology). A PCR-based deletion
strategy (44)was employed, usingDNA fragments encoding the
myc3-URA3-myc3 cassette to precisely delete SSY1 and PTR3
open reading frames (myc3 denotes 3 repeats of a nucleotide
sequence encoding themyc epitope, flanked on either side by 50
bp of sequences identical to the sequences of either the SSY1 or
the PTR3 gene, respectively). This technique was employed to
produce deletions of the SSY1 and PTR3 open reading frames.
We then selected for recombination within the myc3-URA3-
myc3 module using 5-fluoroorotic acid, to produce strains
AVY27 (MAT ura3–52 ssy1::myc3) and AVY28 (MAT
ura3–52 ptr3::myc3), and verified the identity of these strains
by Southern hybridization (data not shown). AVY26 (MAT
ura3–52 ubr1::HisG) was also a derivative of RJD347 (Table
1). It was constructed using the same PCR-based deletion strat-
egy (44), except that a HisG-URA3-HisG cassette (see below)
was used. Strains AVY30 (MAT leu2–3,112 ubr1::LEU2),
AVY31 (MAT leu2–3,112 cup9::LEU2), and AVY32 (MAT
LEU2) (Table 1) were derivatives of RJD350 (MAT leu2–
3,112) (a gift from Dr. R. Deshaies).
PCR with S. cerevisiae genomic DNA was used to produce a
fragment containing SSN6 flanked by 901 bp and 400 bp of
upstream and downstream sequences, respectively. The frag-
ment was ligated to NotI/EcoRI-cut pRS314 (45). The same
procedure was used to construct a fragment containing TUP1
flanked by 459 bp and 400 bp of upstream and downstream
sequences, respectively, followed by ligation to SpeI/ClaI-cut
pRS416 (45). pSsn6, which carried ssn6::HisG-URA3-HisG,
was constructed by subcloning the SSN6-containing NotI-
EcoRI fragment into NotI/EcoRI-cut Bluescript (Stratagene),
producing pBlueSSN6. Using PCR, a deletion (from 50 bp
upstream of the SSN6 start codon to position 2,585 of its open
reading frame) was introduced, while simultaneously creating
an EclXI site at the upstream breakpoint of the deletion. The
EclXI-PstI fragment of pAS315 (a gift fromDr.A. Sil, University
of California, San Francisco), containing HisG-URA3-HisG,
was then inserted. In vivo integration of the NotI-EcoRI
fragment of the resulting plasmid (pSsn6), carrying
ssn6::HisG-URA3-HisG, produced a deletion of SSN6 that
spanned the region from 50 to 2585, relative to the start
codon. pTup1, which carried tup1::HisG-URA3-HisG, was
constructed similarly, using the SpeI-ClaI fragment containing
TUP1 (from pTUP1), its subcloning into pBluescript (thus
yielding pBlueTUP1), and PCR to produce a deletion allele of
TUP1 (from 7 bp upstream of its start codon to position 2016 of
the TUP1 open reading frame) that contained a (PCR-added)
BamHI site at the deletion breakpoint. The BamHI-EcoRI frag-
ment of pAS135 was then inserted into pBlueTUP1. In vivo
integration of the SpeI-XhoI fragment of the resulting plasmid
(carrying tup1::HisG-URA3-HisG) produced a deletion of
TUP1, from7 to2016, relative to the start codon. To select
for recombination/excision within the integratedHisG-URA3-
HisG cassette and thereby to produce ssn6::HisG and
tup1::HisG alleles, 5-fluoroorotic acid-resistant yeast colonies
were isolated, and the identities of strains were verified by
Southern hybridization (data not shown). This procedure was
performed in the JD52 background to construct strains AVY60
and AVY61; in the JD55 (ubr1) background (Table 1) (23) to
construct AVY62 and AVY63; in the AVY50 background (1) to
construct AVY64 and AVY65; and in the AVY51 background
(1) to construct AVY66 and AVY67 (Table 1).
SSN6 tagged at the C terminus with two copies of the myc
epitope (SSN6myc2) and expressed from its own promoter on a
high copy (2) plasmid was a gift from Dr. R. Zitomer (State
University of New York, Albany). For plasmid-based comple-
mentation assays, plasmids encoding SSN6 (pSSN6) and TUP1
(pTUP1) were constructed using standard techniques. fDHFR-
UbK48R-CUP9NSF was expressed from the PMET25 promoter in
the plasmid pMET416UPRCUP9NSF, based on the low copy
(CEN) vector p416MET25 (3). The previously described (27)
pUb23-X plasmids expressed X--galactosidase reporter pro-
teins (derived from the corresponding Ub-X--galactosidase
fusions; XMet, Ala, His, or Tyr) from the PGAL1 promoter in
a high copy vector.
Coimmunoprecipitation, Pulse-chase, -Galactosidase, and
Northern Hybridization Assays—For CUP9-SSN6 coimmuno-
precipitation assays, S. cerevisiae carrying the indicated plas-
mids were grown to A600 of1 in SD medium (12) containing
auxotrophic supplements. Cells from a 10-ml culture were har-
vested by centrifugation, washed in 1 ml of water, and resus-
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pended in 0.8ml of ice-cold buffer C (0.25 MNaCl, 1mMEDTA,
50 mMHEPES, pH 7.5) containing ovalbumin at 1 mg/ml. Cells
were disrupted by vortexing with 0.5 ml (packed volume) of
0.5-mm glass beads in the presence of protease inhibitors
(Roche Applied Science). Extracts were prepared and immuno-
precipitations were carried out as described (46), with two
modifications. First, after incubation of an extract with anti-
FLAG beads (Sigma) for 45 min at 4 °C, the resulting immuno-
precipitate was washed once with 1 ml of buffer C, and then
twice more with 1 ml of buffer C lacking ovalbumin. Second,
immunoprecipitates were eluted from anti-FLAG beads
through a 15-min incubation, at room temperature, with the
FLAG peptide at 0.5 mg/ml, in buffer C lacking ovalbumin.
An equal volume of 2 SDS-PAGE sample buffer was added,
followed by SDS-13% PAGE and immunoblotting with anti-
myc antibody (Covance, Berkeley, CA), followed by a sec-
ondary horseradish peroxidase-conjugated goat anti-mouse
antibody (Bio-Rad) at 1:1,000 dilution, and thereafter a
detection of the latter antibody using ECL assay (GE Health-
care, Piscataway, NJ).
For pulse-chase assays, S. cerevisiae was grown to A600 of
0.8 in SHM medium (2% glucose, 0.1% allantoin, and 0.17%
yeast nitrogen base without amino acids and without ammo-
nium sulfate) that either contained or lacked tryptophan (98
M, 20 g/ml), an inducing amino acid (32). Cells were har-
vested, washed in 0.8 ml of SHM Trp, resuspended in 0.4 ml
of the same medium, and labeled for 5 min at 30 °C with 0.16
mCi of 35S-EXPRESS (PerkinElmer Life Sciences). Thereafter
cells were pelleted, resuspended in fresh SHM  tryptophan
containing 4 mM L-methionine and 2 mM L-cysteine, and incu-
bated further at 30 °C. Samples of 0.1mlwere taken at indicated
time points and transferred to chilled tubes, each containing 0.5
ml of 0.5-mm glass beads, 0.7 ml of ice-cold lysis buffer (1%
Triton X-100, 0.15 M NaCl, 5 mM EDTA, 50 mM HEPES, pH
7.5), and a mixture of protease inhibitors (final concentrations:
1 mM freshly prepared phenylmethylsulfonyl fluoride, 2 g/ml
aprotinin, 0.5 g/ml leupeptin, and 0.7 g/ml pepstatin).
Extracts were prepared, and immunoprecipitations were car-
ried out as described previously (46), using anti-FLAG M2
beads (Sigma). Immunoprecipitated proteins were fractionated
by SDS-13% PAGE, followed by autoradiography. Some of the
pulse-chase assayswere carried out in the presence of cyclohex-
imide (at 0.2 mg/ml) during the chase.
For -galactosidase (gal) activity assays, S. cerevisiae carry-
ing a pUB23-X plasmid (27) and expressing, from the PGAL1
promoter, an X-gal test protein (derived from Ub-X--galac-
tosidase, with X  Met, Ala, His, or Tyr) (47) were grown in
SHMmedium overnight. Cultures were diluted toA600 of0.1
in SHM containing 2% galactose instead of glucose and either
containing or lacking 98 M Trp, followed by growth until A600
of 0.5. Cell extracts were thereafter prepared and processed
for assays with o-nitrophenyl o-nitrophenyl--D-galactopyran-
oside as previously described (27). For Northern analyses of
PTR2 induction by amino acids, cells were grown to A600 of
0.6 in SHMcontaining or lacking 98M (20g/ml)Trp. Total
RNA was prepared as described previously (16), using an
RNeasy Mini Kit (Qiagen, Valencia, CA). Samples containing
25 g of RNA were electrophoresed in 1% formaldehyde-agar-
ose gels, followed by blotting for Northern analysis (3). North-
ern assays of the effects of deletions of specific genes on PTR2
expression were carried out identically, in the absence of added
Trp.
RESULTS ANDDISCUSSION
Repression of PTR2 Transcription by CUP9 Involves the
CUP9-TUP1-SSN6 Corepressor Complex—UBR1, the E3 Ub
ligase of the S. cerevisiae N-end rule pathway, regulates the
import of peptides by controlling, through degradation of the
transcriptional repressor CUP9, the expression of the peptide
transporter PTR2 (1). PTR2 mRNA was originally shown to
be absent in ubr1 cells (1, 48), consistent with amechanism in
which a normally short-lived repressor of PTR2 becomes long-
lived in the absence of UBR1, thereby increasing in concentra-
tion and shutting down PTR2 transcription. CUP9 was identi-
fied using a bypass screen formutations that restored dipeptide
uptake and PTR2 expression in ubr1 cells (1).
Further analysis, described below, of our collection of bypass
mutants identified additional isolates that did not belong to the
CUP9 complementation group. Many of these non-cup9
mutants (Fig. 1A) exhibited flocculation (aggregation during
growth in liquid culture) and had a reduced mating ability.
These phenotypes are characteristic of a defect in either TUP1
or SSN6, which encode two “global” corepressors that form a
complex interfering with transcription initiation (reviewed in
Ref. 49). The TUP1-SSN6 complex, which does not bind to
DNA by itself, is recruited to individual promoters through
interactions with specific DNA-binding proteins. One such
protein is the mating-type regulator MAT2 (50). In the
absence of either TUP1 or SSN6, theMAT2-mediated repres-
sion of MATa-specific genes is defective, resulting in mating-
defective, pseudodiploid cells (49).
To determine whether the above non-cup9 isolates (Fig. 1A)
were either tup1 or ssn6 mutants, they were transformed with
low copy plasmids that expressed either TUP1 or SSN6 from
their natural promoters. These plasmids indeed suppressed the
clumpy-growth and peptide-uptake phenotypes of all of the
flocculating bypass mutants. The entire collection of our 201
bypass mutants (including cup9mutants) was partitioned into
complementation groups using a combination of the above
plasmid-based complementation tests as well as mating-based
complementation assays (the latter could not be comprehen-
sive, owing to mating deficiency of some isolates). The 201
bypass suppressors were found to belong to three complemen-
tation groups, defined by CUP9, TUP1, and SSN6. Apart from
genes required for cell viability, it is likely that our (noncondi-
tional) screen was an exhaustive one, given the numbers of iso-
lates in each of the three complementation groups thus identi-
fied: 104, 67, and 30 isolates of cup9, ssn6, and tup1 mutants,
respectively (Fig. 1A).
To verify the role of TUP1 and SSN6 in regulating peptide
uptake, we tested the effects of disrupting either one of these
genes on the ability of a ubr1 strain to import dipeptides.
Congenic (tup1 ubr1) and (ssn6 ubr1) double mutants
were constructed using homologous recombination in the
lysine-auxotrophic (lys2) genetic background, and the identi-
ties of mutants were verified by Southern hybridization (data
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not shown). The ability of these Lys-requiring double mutants
to import dipeptides was then assayed by monitoring their
growth on aminimalmedium containing the dipeptide Lys-Ala
as the sole source of Lys (Fig. 1B). A
lys2 strain containing the intact
UBR1 gene was able to import suffi-
cient amounts of Lys-Ala dipeptide
to support its growth on this
medium, whereas a congenic
(ubr1 lys2) strain could not grow
under these conditions (it could be
rescued by free Lys) (Fig. 1B). In
contrast to the ubr1 lys2 strain,
both tup1 ubr1 lys2 and ssn6
ubr1 lys2 triple mutants formed
colonies on Lys-Ala plates, as did a
cup9 ubr1 lys2 strain (Fig. 1B).
Thus, a deletion of either CUP9, or
TUP1, or SSN6 is each capable of
restoring dipeptide uptake to a
ubr1 strain. The slightly smaller
colonies formed by the ssn6 ubr1
lys2 strain on Lys-Ala plates could
be caused by a growth defect of
ssn6 strains, a phenotype that we
also observed with the ssn6 ubr1
lys2 strain on a control (Lys-supple-
mented) plate (Fig. 1B).
The fact that cup9, tup, and ssn6 mutants all bypassed the
block to dipeptide uptake in a ubr1 strain suggested that
CUP9 represses PTR2 expression by functioning as a part of a
TUP1/SSN6-containing complex. To address this model, we
compared the levels of PTR2 mRNA in ssn6 and tup1
mutants with those in other strains, in the absence of added
PTR2 inducers such as dipeptides or amino acids. In a strain
retaining all five of the studied genes, PTR2, UBR1, CUP9,
SSN6, and TUP1, and also in a ubr1 strain, the level of PTR2
mRNA was low enough to be undetectable at the sensitivity of
Northern assays used (Fig. 2A, lanes a and b; compare with
lanes c–i). With ubr1 strains, no PTR2 mRNA could be
detected even by higher sensitivity Northern blots (data not
shown), whereas wild-type (UBR1) strains, in the absence of
either added dipeptides or “inducing” amino acids, contained
low but detectable levels of PTR2mRNA, as shown previously
(1, 3). In contrast, the levels of PTR2 mRNA were high in the
absence of either CUP9, or SSN6, or TUP1, irrespective of the
presence or absence of UBR1 (Fig. 2A, lanes c–i; compare with
lanes a and b; see also Fig. 3A, lane c versus lane i). Thus, the
tight block to dipeptide uptake in a ubr1 strain, caused by
increased levels of the CUP9 repressor, could be bypassed not
only through the removal of CUP9, but also through the
removal of either SSN6 or TUP1 (Fig. 2A).
High levels of PTR2 mRNA in the absence of either CUP9,
SSN6, or TUP1 (Figs. 2A and 3A) indicated that each of these
proteins was essential for repression of the PTR2 gene. Both the
demonstrated functional dependence of CUP9 on SSN6/TUP1
(Figs. 1 and 2A) and the close analogy between the homeodo-
main repressors CUP9 and MAT2, the latter of which is
known to interact with SSN6/TUP1 (see above), suggested that
CUP9 also interacted with SSN6/TUP1. To address this exper-
imentally, we carried out a coimmunoprecipitation assay, using
FIGURE 1.Mutations in SSN6 or TUP1 rescue the block to dipeptide import in ubr1 S. cerevisiae, which
lack the N-end rule pathway. A, a collection of 201 mutants in which the ability of a ubr1 strain to import
dipeptides had been restored (cup9 members of that collection were examined in the earlier study (1)) were
classed into complementation groups that included SSN6 and TUP1 using plasmid-based or mating-based
complementation tests (1). The number of isolates in each complementation group, cup9, tup1, and ssn6, is
shown.B, ssn6 and tup1 restoredipeptide import to aubr1 strain. Strains JD52,AVY107,AVY51,AVY62, and
AVY63 (Table 1),with relevant genotypes indicatedon theplate diagram,were tested for their ability to use the
dipeptide Lys-Ala as a source of essential nutrient, lysine. All strains were lys2 and thus auxotrophic for Lys.
Strains were tested for growth on SD medium lacking Lys (left), or supplemented with Lys-Ala (center), or
supplementedwith Lys (right). Only strains capable of importing dipeptides could form colonies on the [Lys;
[Lys-Ala]] plate. Deletion of either SSN6, TUP1, or (as shownpreviously (1))CUP9 restored dipeptide import to
a ubr1 strain (center plate).
FIGURE 2. CUP9 represses PTR2 transcription via SSN6 and TUP1. A, SSN6,
TUP1, and CUP9 are required for repression of the peptide transporter gene
PTR2. Northern analysis of PTR2 mRNA in the wild-type strain JD52, and in
congenic ssn6 (AVY60), tup1 (AVY61), cup9 (AVY50), and ubr1 (AVY107)
mutants, as well as in various combinations thereof (AVY51 and AVY62–
AVY67) (Table 1). The status of each gene (, deleted;, wild-type allele) is
shown in the upper diagram. PTR2 and ACT1 (actin) mRNA are indicated. S.
cerevisiae strains were grown in SHM without PTR2-inducing amino acids or
peptides. B, coimmunoprecipitation of myc-tagged SSN6 (SSN6myc2) with
CUP9NSF, a FLAG-tagged CUP9 derivative (see “Results” and “Discussion”).
Extracts from cells expressing the indicated combinations of SSN6myc2 and
CUP9NSF were immunoprecipitated with a monoclonal anti-FLAG antibody,
followedbySDS-PAGEand immunoblottingwithamonoclonal anti-mycanti-
body (see “Experimental Procedures”).
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epitope-tagged SSN6 and CUP9 (Fig. 2B). Because overexpres-
sion of wild-type CUP9 inhibits cell growth, most likely owing
to its interactions with DNA (data not shown), we employed a
previously constructed nontoxic derivative of CUP9 (3). CUP9
interacts with DNA through its homeodomain motif. Based on
the previously studied interactions of other homeodomain pro-
teins with DNA, an Asn 3 Ser substitution at position 265,
within the recognition helix of the CUP9 homeodomain, was
predicted to strongly reduce the affinity ofCUP9 forDNAwith-
out causing a significant structural perturbation. This nontoxic
CUP9 derivative, tagged at the C terminus with the FLAG
epitope, was termed CUP9NSF (3).
Extracts were prepared from S. cerevisiae stably expressing
both CUP9NSF and SSN6 (SSN6myc2) (the latter C-terminally
tagged with a double myc epitope), followed by immunopre-
cipitation with anti-FLAG antibody, SDS-PAGE, and immuno-
blotting with anti-myc antibody. SSN6myc2 was coimmunopre-
cipitated with CUP9NSF in this assay (Fig. 2B, lane c). No
SSN6myc2 was detected in immunoprecipitates of extracts from
cells that did not also express CUP9NSF (Fig. 2B, lane b), and the
expression levels of CUP9NSF and SSN6myc2 were similar in
cells that coexpressed the two proteins (data not shown). Thus,
in agreement with the above expectation, these results (Fig. 2B)
suggested that untagged SSN6 and untagged CUP9, at their
(lower) natural expression levels in S. cerevisiae, would also
forma complex that is analogous to the SSN6/MAT2 complex
(49), amodel that accounts for the observed functional interde-
pendence among CUP9, SSN6, and TUP1 (Figs. 1B, 2A, and
3A). Although we did not examine the immunoprecipitated
CUP9NSF-containing complexes for the presence of TUP1,
extensive previous work has established that SSN6 and TUP1
form a stable complex both in vivo and as purified proteins (Ref.
49, and references therein), indicating that it is the complex of
SSN6 and TUP1 that interacts with CUP9, similarly to the pre-
viously characterized interaction between SSN6/TUP1 and
MAT2, another homeodomain repressor (49).
Both CUP9 and UBR1 Are Required for Inducibility of PTR2
by Amino Acids—When an amino acid, particularly a bulky
hydrophobic one such as Leu or Trp, is added to a culture of S.
cerevisiae growing on a poor nitrogen source such as, for exam-
ple, allantoin, cells induce their PTR2 gene and thus increase
their capacity for the import of di/tripeptides (32). Effective
concentrations of extracellular Leu or Trp can be as low as 1M
(32). Previous work has shown that an accelerated degradation
of CUP9 by the UBR1-dependent N-end rule pathway in
response to imported dipeptides with destabilizing N-terminal
residues, strongly enhancesPTR2 expression (3). This result led
us to consider whether other signals that up-regulate PTR2
expression, e.g. amino acids, may also act through acceleration
of CUP9 degradation.
To begin addressing this possibility, we examined the effects
of Trp, a strongly inducing amino acid, on PTR2mRNA levels
in several S. cerevisiae strains, AVY32, AVY24, AVY25, AVY30,
and AVY31, that were constructed to be completely prototro-
phic, and in particular did not require extracellular amino acids
for viability (Table 1). These strains were grown in allantoin-
based media (SHM) containing or lacking Trp. Allantoin is a
nonrepressing nitrogen source (32), so the expression of PTR2
was not influenced by the nitrogen catabolite repression under
these conditions. PTR2 mRNA levels were extremely low in
wild-type UBR1 CUP9 cells grown in medium lacking amino
acids, but in the presence of 98 M (20 g/ml) Trp the expres-
sion of PTR2 was greatly increased (Fig. 3A, lanes a and b). By
contrast, in the absence of CUP9 (in a cup9 strain), PTR2 was
highly expressed in either the presence or absence of Trp (Fig.
3A, lanes i and j; compare with lanes a and b). Finally, PTR2
mRNA was undetectable in a ubr1 strain grown in either the
presence or absence of Trp (Fig. 3A, lanes c and d). Thus, both
UBR1 and CUP9 are required for inducibility of PTR2 expres-
sion by an amino acid.
Three genes, SSY1, PTR3, and SSY5, are a part of the SPS
amino acid-sensing pathway in S. cerevisiae (see introduction).
FIGURE 3. Northern analyses of PTR2 and UBR1 under different condi-
tions and in different genetic backgrounds. A, amino acid-inducible
expression of PTR2 requiresUBR1 andCUP9. Congenic strains of the indicated
genotype (AVY32, AVY30, AVY24, AVY25, andAVY31) (Table 1) were grown in
SHM medium containing or lacking 98 M (20 g/ml) tryptophan. Isolated
total RNA was analyzed by Northern hybridization with PTR2 and ACT1 DNA
probes, as indicated. B and C, levels of UBR1 expression do not change signif-
icantly in the presence versus absence of Trp. Total RNA from the strains
AVY30-AVY32 (Table 1)was analyzedbyNorthern hybridizationwithUBR1 (B)
and ACT1 (C). Lane a, RNA from ubr1 cells (negative control). Lanes b and c,
RNA from wild-type (UBR1) cells either in the presence or absence of added
Trp (98 M). Lanes d and e, same as lanes b and c, but RNA from cup9 cells.
D, Trp-mediated induction of PTR2 inwild-type andmutant S. cerevisiae. Total
RNAwas isolated from congenic strains of indicated genotypes either before
the addition of 98 M Trp, or 20 min thereafter, or 60 min thereafter, and the
relative levels of PTR2 mRNA were determined by Northern hybridization.
E, ethidium-stained rRNA (loading controls) in agarose gel before the transfer
of RNA to hybridization membrane.
Induction of Peptide Import
OCTOBER 24, 2008•VOLUME 283•NUMBER 43 JOURNAL OF BIOLOGICAL CHEMISTRY 28963
 at CALIFO
RNIA INSTITUTE O
F TECHNO
LO
G
Y on O
ctober 17, 2008 
w
w
w
.jbc.org
D
ow
nloaded from
 
We examined the influence of added Trp on the levels of PTR2
mRNA in ssy1 and ptr3 strains, comparing the conse-
quences of deleting these genes with the effects of deleting
either CUP9 or UBR1. The induction of PTR2 by Trp was dra-
matically reduced in both ssy1 and ptr3 strains (Fig. 3A,
lanes e–h). However, a weak Trp-mediated increase in PTR2
expression was still observed in these strains, in contrast to the
complete absence of PTR2 expression (and of Trp effect) in
ubr1 cells, and in contrast to a high level of PTR2 mRNA in
cup9 cells (Fig. 3A). Thus the bulk (but apparently not all) of
the Trp effect on the expression of PTR2 requires SSY1 and
PTR3.
We next examinedwhether the general amino acid permease
GAP1 (37) was required for Trp-mediated induction of PTR2
mRNA. Expression of PTR2 in wild-type cells and a congenic
gap1 strain was measured by Northern analysis as a function
of time after the addition of Trp. Wild-type cells exhibited a
strong induction of PTR2 by 20min in the presence of Trp (Fig.
3, D and E, lanes a–c). Remarkably, the induction of PTR2 by
Trp, while still occurring in the absence of GAP1, was found to
be strongly decreased (Fig. 3, D and E, lanes d–f; compare with
lanes a–c). To the best of our knowledge, this is the first indi-
cation of a major involvement of GAP1 in the amino acid-me-
diated induction of the PTR2 peptide transporter. Being an
inducer of PTR2 and other transporter genes via the amino acid
sensor SSY1, the extracellular Trp exerts its effect without its
import across the plasmamembrane (see introduction). There-
fore the absence of GAP1 as an importer of Trp would not be
expected,apriori, to influence the PTR2-inducing effect of Trp.
Moreover, Trp can also be imported by the Trp-specific per-
mease TAP2 (SCM2) (51). In sum, the observed decrease (but
not elimination) ofPTR2 induction in the absence ofGAP1 (Fig.
3, D and E, lanes a–f) stems from a function of GAP1 that is
separate from its role as a transporter of amino acids. Indeed, S.
cerevisiae GAP1 is known to function as an amino acid sensor
for activation of protein kinase A targets. The protein kinase A
and SCH9 kinases have both overlapping and distinct functions
in controlling the adaptation of S. cerevisiae to nutrient avail-
ability, and GAP1 plays a role at least in the protein kinase
A-mediated part of this circuit (Ref. 52, and references therein).
Thus, although the mechanistic understanding of involvement
of GAP1 in the induction of PTR2 by Trp remains to be
attained, the above finding (Fig. 3, D and E) revealed a new
aspect of PTR2 control and yet another function of GAP1 as a
nutritional regulator.
We also measured, in the gap1 background, the influence of
STP1 and/or STP2 on the Trp-mediated induction of PTR2
mRNA. STP1 and STP2 are two sequelogous, conditionally
active transcriptional activators that mediate the signaling by
the SPS pathway (see introduction) (35, 39, 40, 43). Northern
analyses of PTR2 expression as a function of time after addition
of Trp showed that the Trp-mediated induction of PTR2 was
largely retained in a gap1 stp1 strain (which lacked the STP1
transcriptional activator), in comparison to congenic gap1
strain, whereas the STP2 transcriptional activator was essential
for PTR2 induction by Trp: both a gap1 stp2 mutant and a
triple mutant gap1 stp1 stp2 did not exhibit a significant
induction of PTR2 by Trp, in contrast to parental gap1 and
gap1 stp1 strains (Fig. 3, D and E). Thus, as could be
expected from the presence of STP1/2-recognized UASAA
nucleotide sequence motifs (53) upstream of the PTR2 gene
(data not shown), the induction ofPTR2 proceeds both through
its transcriptional up-regulation, in particular by the Trp-acti-
vated STP2 (Fig. 3, D and E), and through a decrease in its
repression, owing to the Trp-induced acceleration of degrada-
TABLE 1
S. cerevisiae strains used in this study
Strain Relevant genotype Reference
JD52 MATa ura3-52 his3-200 leu2-3,112 trp1-63 lys2-801 (56)
JD55 MATa ura3-52 his3-200 leu2-3,112 trp1-63 lys2-801 ubr1-1::HIS3 (56)
AVY24 MAT ura3-52 ssy1::myc3-URA3-myc3 This study
AVY25 MAT ura3-52 ptr3::myc3-URA3-myc3 This study
AVY26 MAT ura3-52 ubr1::HisG This study
AVY27 MAT ura3-52 ssy1::myc3 This study
AVY28 MAT ura3-52 ptr3::myc3 This study
AVY30 MAT leu2-3,112 ubr1::LEU2 (3)
AVY31 MAT leu2-3,112 cup9::LEU2 (3)
AVY32 MAT LEU2 (3)
AVY50 MATa ura3-52 his3-200 leu2-3,112 trp1-63 lys2-801 cup9::LEU2 CBY19 in Ref. 1
AVY51 MATa ura3-52 his3-200 leu2-3,112 trp1-63 lys2-801 ubr1::HIS3 cup9::LEU2 CBY17 in Ref. 1
AVY60 MATa ura3-52 his3-200 leu2-3,112 trp1-63 lys2-801 ssn6::HisG This study
AVY61 MATa ura3-52 his3-200 leu2-3,112 trp1-63 lys2-801 tup1::HisG This study
AVY62 MATa ura3-52 his3-200 leu2-3,112 trp1-63 lys2-801 ubr1::HIS3 ssn6::HisG This study
AVY63 MATa ura3-52 his3-200 leu2-3,112 trp1-63 lys2-801 ubr1::HIS3 tup1::HisG This study
AVY64 MATa ura3-52 his3-200 leu2-3,112 trp1-63 lys2-801 cup9::LEU2 ssn6:::HisG This study
AVY65 MATa ura3-52 his3-200 leu2-3,112 trp1-63 lys2-801 cup9::LEU2 tup1::HisG This study
AVY66 MATa ura3-52 his3-200 leu2-3,112 trp1-63 lys2-801 ubr1::HIS3 cup9::LEU2 ssn6::HisG This study
AVY67 MATa ura3-52 his3-200 leu2-3,112 trp1-63 lys2-801 ubr1::HIS3 cup9::LEU2 tup1::HisG This study
AVY107 MATa ura3-52 his3-200 leu2-3,112 trp1-63 lys2-801 ubr1::myc3 (3)
RJD347 MAT ura3-52 A gift from Dr. R. Deshaies
RJD350 MAT leu2-3,112 A gift from Dr. R. Deshaies
M4272 MATa SUC2 mal gal2 CUP1 ura3  gap1  stp1  stp2 (57)
M4270 MATa SUC2 mal gal2 CUP1 ura3  gap1  stp2 (57)
M4173 MATa SUC2 mal gal2 CUP1 ura3  gap1  stp1 (57)
M4054 MATa SUC2 mal gal2 CUP1 ura3  gap1 (57)
M3750 MATa SUC2 mal gal2 CUP1 ura3 (58)
23344c MAT, ura3 (59)
JA115 MAT grr1::kanMX2 ura3 (59)
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tion of the CUP9 repressor by the N-end rule pathway, as
described below (Fig. 4).
The SPS Pathway Induces PTR2 Expression through Acceler-
ation of CUP9 Degradation—Some of the above results (Fig.
3A) suggested that the induction of PTR2 transporter by amino
acids might occur through an increase in the rate of degrada-
tion of CUP9 repressor. A precedent for this possibility was the
previously demonstrated acceleration of CUP9 degradation by
dipeptides with destabilizing N-terminal residues (3). In the
latter case, the bulk of CUP9 degradation, both before and after
the addition of dipeptides to themedium,was carried out by the
UBR1-dependent N-end rule pathway (3). To determine
whether the rate of CUP9 degradation was altered by a PTR2-
inducing amino acid such as Trp, we carried out pulse-chase
assays with CUP9. These experiments utilized CUP9NSF, the
above-described nontoxic, single-residue mutant of CUP9.
CUP9NSF was expressed as an fDHFR-UbK48R-CUP9NSF fusion,
where fDHFR is the N-terminally FLAG-tagged mouse dihy-
drofolate reductase. Deubiquitylating enzymes cotranslation-
ally cleave this fusion at theUbK48R-CUP9NSF junction, yielding
the long-lived reference protein fDHFR-UbK48R and the test
protein CUP9NSF (3). The reference fDHFR-UbK48R served as a
“built-in” internal control for variations in expression levels and
immunoprecipitation efficiency. This generally applicable
method, called the Ub-protein-reference (UPR) technique
(Refs. 12, 47, and references therein), increases the accuracy of
pulse-chase assays. The in vivo degradation of CUP9NSF was
indistinguishable from that of wild-
type CUP9 and was also not altered
significantly by the incorporation of
this protein into the above (co-
translationally processed) UPR-
type fusion (3).
We expressed CUP9NSF from a
URA3-bearing plasmid in S. cerevi-
siae strains that did not require
extracellular amino acids for viabil-
ity (RJD347, AVY26, AVY27, and
AVY28; see Table 1). In wild-type
(UBR1) cells grown in the SHM
medium lacking amino acids,
CUP9NSF was degraded with t1⁄2 of
10 min (Fig. 4, A, B, E, and F).
Remarkably, the addition of Trp (to
98 M, or 20 g/ml) to the medium
resulted in a strong acceleration
of CUP9NSF degradation, with t1⁄2 of
2 min between 0 and 5 min of
chase, and even 2 min between 5
and 10 min of chase (Fig. 4, A, B, E,
and F). This effect of Trp on the rate
of CUP9NSF degradation was repro-
ducible in separate and independent
pulse-chase assays, including a set of
assays in which cycloheximide, a
translation inhibitor, was present
during chase (Fig. 4, C and G). (The
other assays, in Fig. 4 (A, B, E, and F)
did not involve cycloheximide.) Although in cycloheximide-
based assays (Fig. 4, C and G) the CUP9NSF protein was
degraded more slowly (t1⁄2 of 20 min and 3–4 min in the
absence and presence of Trp, respectively) than in cyclohexim-
ide-free assays (Fig. 4, A, B, E, and F), the effect of Trp was
comparably strong in both cases (Fig. 4). In addition to increas-
ing the accuracy of pulse-chase assays, the UPR technique, spe-
cifically its built-in, long-lived reference protein, makes it pos-
sible to determine the relative level of a test protein (measured
as the ratio of 35S in a test versus reference protein) at the begin-
ning of chase, i.e. at the end of pulse labeling (12). In Fig. 4
(E–G), 100% was assigned, in each of three panels, to the rela-
tive amount of 35S (relative to the reference protein) of
CUP9NSF at time “0” (the end of pulse labeling) in the absence of
Trp in the medium. Thus, a value below 100% at time “0”
reflects the relative extent of CUP9NSF degradation during the
5-min pulse. In all of pulse-chase assays (Fig. 4, E–G), these
initial (time-zero) levels of CUP9NSF were found to correlate,
consistently, withTrp-induced changes in the rates ofCUP9NSF
degradation that were measured during the chase.
The presence of SSY1 (Fig. 4, A and E) and also, independ-
ently, of PTR3 (Fig. 4, B and F) was found to be strongly but
partially required for the Trp-accelerated degradation of
CUP9NSF. Specifically, the bulk of enhanced degradation of
CUP9NSF upon the addition of Trp was absent in ssy1 and
ptr3 mutants (Fig. 4, A, B, E, and F). Interestingly, however,
the degradation of CUP9NSF was still detectably accelerated by
FIGURE 4. The bulk of Trp-accelerated CUP9 degradation requires SSY1, PTR3, and UBR1. Pulse-chase
analyses, using the UPR technique and fDHFR-UbK48R reference protein, of the CUP9 degradation. S. cerevisiae
of the indicated genotypes were grown in SHMmedium containing or lacking 98M Trp (20g/ml). [35S]Met/
Cys labeling for 5min, followed by chases for 5 and 10min (A and B) or for 5, 15, and 30min (C andD), the latter
with cycloheximideat 0.2mg/ml. Eand F, PhosphorImager-basedquantitationofpulse-chasepatterns inAand
B, respectively. Closed circles and triangles, wild-type cells, without and with added Trp, respectively. Open
circles, either ssy1 cells (A) or ptr3 cells (B) in the absence of added Trp.Open triangles, same but with added
Trp.G, quantitation of pulse-chase patterns in C andD. Closed circles and triangles, wild-type cells, without and
with addedTrp, respectively.Open circles and triangles, samebutwithubr1 cells. Data inC,D, andGwere from
experiments independent of those in A, B, E, and F, and in addition were carried out with cycloheximide. See
“Experimental Procedures” for additional details.
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Trp in thesemutant strains (Fig. 4,A, B, E, and F), in agreement
with the weak but still detectable induction, by Trp, of PTR2
mRNA in ssy1 and ptr3 mutants (Fig. 3A). As we observed
previously as well (3), CUP9NSF was greatly but not completely
stabilized in ubr1 cells (Fig. 4G and data not shown). Interest-
ingly, the addition of Trp to ubr1 cells resulted in a weak but
still detectable Trp-induced destabilization of the (now long-
lived) CUP9NSF, despite the absence of the N-end rule pathway
(Fig. 4G, open circles versus open triangles). The “residual”
(UBR1-independent) instability of CUP9NSF and the residual
sensitivity of this degradation to Trp suggest that CUP9 may
also be targeted, at a much lower rate, by a UBR1-independent
proteolytic pathway. Our attempts to identify a relevant E3 Ub
ligase, through the testing of non-UBR1 E3 mutants, have not
been successful, thus far (data not shown).
The Levels of UBR1 mRNA Are Not Changed Significantly by
a PTR2-inducing Amino Acid—Previous work has shown that
the in vivo concentration of UBR1 is rate-limiting for degrada-
tion of N-end rule substrates by the S. cerevisiae N-end rule
pathway (reviewed in Ref. 5). To determine whether the Trp-
induced acceleration of CUP9 degradation (Fig. 4) was accom-
panied by an increased level of the UBR1 Ub ligase, we used
Northern hybridization to compare the levels of UBR1mRNA
before and after the addition of Trp. Extracellular Trp did not
cause a significant alteration in the levels of UBR1mRNA (Fig.
3,B andC). Togetherwith findings described in the next section
(Fig. 5), these results (Fig. 3,B andC) strongly suggested that the
observed acceleration of CUP9 degradation in the presence of
extracellular Trp (Fig. 4) was not caused by increased levels of
UBR1. In addition, the levels of UBR1 mRNA remained the
same or nearly the same in the absence of CUP9 (Fig. 3, B and
C), indicating that UBR1 is not a part of the CUP9 regulon.
Degradation of Reporter Proteins Bearing N-degrons Is Not
Changed Significantly by a PTR2-inducing Amino Acid—CUP9
lacks an N-degron and is recognized by the UBR1 Ub ligase
through a C terminus-proximal degron (see introduction). To
determine whether the acceleration of CUP9 degradation by
Trp (Fig. 4) was accompanied by increased activity of theN-end
rule pathway toward substrates with N-degrons, we employed
X-gal reporters. They were produced through cotranslational
deubiquitylation of the corresponding Ub-X-gal fusions,
where X was a variable residue (47, 54). Previous work has
shown that the enzymatic activity of gal in extracts from cells
that expressed an X-gal reporter protein was a reliable meas-
ure of the reporter’s metabolic stability in vivo (27). Of the four
X-gal reporters in Fig. 5, Met-gal and Ala-gal had stabiliz-
ing N-terminal residues, whereas His-gal and Tyr-gal had,
respectively, a type-1 and type-2 primary destabilizing N-ter-
minal residues. As would be expected from the UBR1-depend-
ent degradation of His-gal and Tyr-gal (5), their levels in
wild-type (UBR1) cells weremuch lower than the levels of long-
livedMet-gal andAla-gal under the same conditions (Fig. 5).
We found that the addition of Trp, which led to a strong accel-
eration of the UBR1-dependent degradation of CUP9 (Fig. 4),
did not result in significant alterations of the relative steady-
state levels of His-gal and Tyr-gal reporters, in comparison
to those of Met-gal and Ala-gal (Fig. 5). These findings were
independently confirmed by carrying out pulse-chase assays
withX-gal reporter proteins (data not shown). Thus the activ-
ity of the N-end rule pathway toward substrates with N-de-
grons did not change significantly upon the addition of Trp.
Concluding Remarks—Extracellular Trp does not increase
the activity of the N-end rule pathway toward its N-degron-
bearing substrates, whereas it does accelerate degradation of
the CUP9 repressor by the same pathway (Figs. 4 and
5), thereby making possible the induction of the PTR2 peptide
transporter. This dichotomy constrains possible interpreta-
tions of our findings. Yet another constraint stems from the fact
that the bulk of the Trp-induced acceleration of CUP9 degra-
dation by the N-end rule pathway requires the amino acid-
sensing SPS pathway (Figs. 3A and 6). CUP9 is targeted for
degradation via its internal degron, through its interaction with
a third substrate-binding site of the UBR1 E3 Ub ligase, which
functions as the UBR1-RAD6 holoenzyme (see introduction).
The autoinhibitedCUP9-binding site of UBR1 can be activated,
allosterically, by dipeptides with destabilizing N-terminal resi-
dues that interact with the other two (type-1 and type-2) bind-
ing sites ofUBR1 (2, 3). Conformational equilibria, in the in vivo
ensembles that contain UBR1, would determine a fraction of
UBR1 that is active toward CUP9. We suggest that such equi-
libria can be shifted toward CUP9-targeting conformations of
UBR1 not only in response to UBR1-binding di/tripeptides, as
demonstrated previously (2, 3), but also through other routes,
for example UBR1 phosphorylation. Other studies have shown
FIGURE 5. Relative metabolic stabilities of X-gal test proteins in the
absence or presence of added tryptophan. In vivo degradation of X-gal
proteins (X  Met, Ala, His, or Tyr) was assessed by comparing their steady-
state levels in wild-type S. cerevisiae in the absence or presence of added Trp.
In contrast to CUP9, which is targeted for UBR1-dependent degradation
through its internal, C terminus-proximal degron, the short-lived His-gal
and Tyr-gal (bearing, respectively, a type-1 and type-2 destabilizing N-ter-
minal residue) are targeted by UBR1 via their respective N-degrons.
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that signaling by the SSY1 sensor of amino acids that results in
the PTR3/SSY5-dependent (proteolytic) activation of the latent
transcription factors STP1 and STP2 is mediated, at least in
part, by an increased phosphorylation of PTR3, in reactions
mediated by the SSY1-associated YCK1/YCK2 kinases (35, 40,
55). In sum, a parsimonious, testablemodel that can account for
our findings (Figs. 1–5) and is also consistent with other evi-
dence is that the Trp-activated signaling by the SPS system (Fig.
6)may increase the rate of CUP9 degradation by theN-end rule
pathway through a phosphorylation of the UBR1 Ub ligase.
This phosphorylation may be mediated, at least in part, by
the previously described SSY1-associated kinases that mediate
the SSY1-induced phosphorylation of PTR3 (35, 40, 55). (As
shown in Figs. 3 and 4, both SSY1 and PTR3 are required for the
bulk of Trp-induced acceleration of CUP9 degradation.)
Our recent findings6 indicate that UBR1 is a multiply phos-
phorylated protein. They also indicate that UBR1 phosphoryl-
ation involves a set of kinases that includes YCK1/YCK2, and
that the resultingmodifications ofUBR1 regulate its functions.6
Work is underway to dissect UBR1 phosphorylation in vivo and
to determine whether specific kinds of phosphorylated UBR1
underlie the Trp-induced acceleration of degradation of the
CUP9 repressor (Fig. 4). Work is also underway to identify
one or more putative E3 Ub ligases that appears to mediate the
residual degradation of CUP9 in ubr1 cells, which lack the
N-end rule pathway. Yet another aspect of these circuits that
remains to be understood is a mechanism that underlies our
finding (Fig. 3, D and E) that the general amino acid permease
GAP1 contributes to the induction of PTR2 by Trp. Given
recent studies of GAP1 as an amino acid sensor (Ref. 52 and
references therein), its Trp-mediated effect on PTR2 is likely to
involve a phosphorylation-based pathway. A better under-
standing of spatiotemporal aspects of CUP9 regulation would
also be important. Because steady-state levels of (short-lived)
CUP9 in wild-type cells are very low, and because overexpres-
sion of wild-type CUP9 is toxic, this and previous studies (2, 3)
utilized CUP9NSF, amissensemutant that does not bind to cog-
nate DNA sites that CUP9 normally recognizes. The Trp-in-
duced acceleration of CUP9NSF degradation (Fig. 4) implies
that in vivo interactions of CUP9 with DNA do not play a sig-
nificant role in the Trp effect. Nevertheless, it would be impor-
tant to determine whether wild-type CUP9 can be targeted for
degradation by the N-end rule pathway directly at sites of its
association with DNA in vivo, whether amodification of CUP9,
e.g. its phosphorylation, might also be involved in the Trp-in-
duced, UBR1-dependent acceleration of CUP9 degradation,
and whether this degradation takes place in the context of
CUP9-containing complexes such asCUP9-SSN6-TUP1. Some
of the other transcriptional repressors, such as MAT2, are
metabolically stabilized by their association with SSN6-TUP1
(50).
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